Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05827185Phase 2Completed
Phase 2, randomised, single-blind trial (4 arms), sponsored by Prince Sattam bin Abdulaziz University. Primary endpoint: Cervicogenic Headache frequency at 6 months. Started May 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05827185.